This Week's CGT News: World's First Solid Tumor CAR T Approved in China
06/30/2026
5 min read
News
False
Advertisement
Related Content
Cell & Gene
Don’t Forget CDx Developers
November 7, 2014
0 min read
Many drug developers are going ‘full steam ahead’ with personalized medicine strategies. They would be wise to consider a more equitable business model for an essential partner in the process: the developer of the companion diagnostic.
Cell & Gene
Bioprocessing
Biopharma
The Next Decade of Cell and Gene Therapies
April 2, 2025
5 min read
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
Regulation & Standards
Business & Trends
Cell & Gene
Peter Marks Resigns from FDA
April 1, 2025
3 min read
Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”
Business & Trends
Regulation & Standards
Cell & Gene
The Trump Effect on Cell and Gene: Science versus Shockwaves
April 1, 2025
9 min read
Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track.